Abstract:OBJECTIVE To analyze the expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors and their relationship with clinical pathological features. METHODS The expressions of Ki67, PCNA protein and mitotic index in ovarian tissues from 20 patients with normal ovarian tissues, 28 patients with ovarian benign tumors, 20 patients with borderline tumors and 109 (73 metastatic ovarian cancer) patients with malignant tumors were retrospectively tested using the American GBI immunohistochemistry two-step method. The expressions of Ki67 and PCNA mRNA were also detected by in situ hybridization (ISH) in ovarian tissues from 37 patients with primary ovarian cancer, 14 patients with borderline tumors, 11 patients with benign tumors and 12 patients with normal ovarian tissues. The relationship between clinical pathologic parameters and the expressions of Ki67 and, PCNA and mitotic index in human ovarian tumors was analyzed. RESULTS (1) The expressions of Ki67 mRNA and protein in ovarian epithelial tumors was higher than in the controls (P = 0.003; P = 0.009; P = 0.001; P = 0.001). But no significant differences appeared in the expression and overexpression of PCNA mRNA and pratein (P = 0.327; P = 0.718; P = 0.123; P = 0.125). Positive correlations between the expressions of mRNA and protein for Ki67 and PCNA were found (r = 0.449, P = 0.025; r = 0.484, P = 0. 014). (2) The expression of Ki67 in ovarian epithelial was higher in low differential carcinoma and at FIGO III-IV stage (P = 0.008; P = 0.007). The expression of Ki67 protein in serous tumor tissues was high, but low or missed in other types of tumor tissues such as malignant mixed mullerian tumor and transitional cell carcinoma (P = 0. 018). No significant differences in other clinicopathological features were found. The high expression of PCNA did not coincide with histological grading, clinical stage and histological types (P = 0.447; P = 0.763; P = 0.657). There were 72 patients with high mitotic index (66.1%). The high expression of mitotic index coincided with histological grading and clinical stage, but not with histological types (P = 0.002; P = 0.040). (3) The combined overexpression of Ki67 and high mitotic index occurred in 57 patients, which coincided with histological grading, clinical stage and histological types (P = 0.018; P = 0.001; P = 0.020). (4) In the 73 patients with metastatic ovarian cancers, the expressions of Ki67 (58.9%), PCNA protein (91.8%) and high MI (61.6%) in primary cancer tissues were greater than in the metastatic cancer tissues (peritoneum and epiploon, Ki67 41.4%, P = 0.031; PCNA 74%, P = 0.004; high MI 38.4%, P = 0.005). The positive intensity of Ki67 protein expression in primary ovarian cancers was significantly higher than in metastatic ovarian cancers (P = 0.040). There was no significant difference in positive intensity of PCNA between primary and metastatic ovarian cancers (P = 0.514). CONCLUSION Ki67 and mitotic index can serve as biomolecular markers for predicting the proliferation of malignant ovarian epithelial tumors. PCNA can not discriminate between benign and malinant ovarian tumors.

Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix.

Proliferative Activity in Cervical Intraepithelial Neoplasia and Cervical Carcinoma.

Relation of Proliferation and Apoptosis Indexes to the Invasiveness of Pituitary Adenomas

Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases

Measures of Cell Turnover (apoptosis and Proliferation) and Their Association with Survival in Gastric Cancer

Combined Evaluation of Preoperative Serum CEA and CA125 As an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma

Anti-apoptotic Proteins, Apoptotic and Proliferative Parameters and Their Prognostic Significance in Cervical Carcinoma.

Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma

[Cell Balance Between Apoptosis and Proliferation in Colon Cancer and Its Correlation with Prognosis].

Combined proliferation and apoptosis index provides better risk stratification in breast cancer

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma

[Correlation Between Apoptotic Index, Bcl-2 Protein Expression and Progression and Prognosis in Breast Carcinoma].

Evaluation of Expression of Apoptosis-Related Proteins and Their Correlation with HPV, Telomerase Activity, and Apoptotic Index in Cervical Cancer

Apoptotic Index Correlates to Bcl-2 and P53 Protein Expression, Histological Grade and Prognosis in Invasive Breast Cancers.

Relationship Between the Expression of Ki-67 and the Apoptosis Cell in Cervical Carcinoma

[Expressions of Ki67, PCNA and Mitotic Index in Ovarian Epithelial Tumors].

Analysis of Factors Affecting the Prognosis of Patients with Cervical Intraepithelial Neoplasia 2

Relationship between the proliferative activity and the overexpression of MUC1 in gastric carcinoma

Expression of p73, PTEN and Ki-67 Proteins in Endometrioid Adenocarcinoma and Their Significance

Microvessel Density and Cell Proliferative Index in Cardiac Adenocarcinoma

The Influence of Tumor Related Gene N-myc, Fas, MTA1 and Nm23-H1 to Proliferation and Metastasis of Endometrial Adenocarcinoma Cell